A detailed history of Atria Investments LLC transactions in Glaukos Corp stock. As of the latest transaction made, Atria Investments LLC holds 6,024 shares of GKOS stock, worth $910,949. This represents 0.01% of its overall portfolio holdings.

Number of Shares
6,024
Previous 7,080 14.92%
Holding current value
$910,949
Previous $837,000 6.33%
% of portfolio
0.01%
Previous 0.01%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 01, 2024

SELL
$113.62 - $135.39 $119,982 - $142,971
-1,056 Reduced 14.92%
6,024 $784,000
Q2 2024

Aug 13, 2024

BUY
$89.48 - $118.35 $633,518 - $837,918
7,080 New
7,080 $837,000
Q1 2020

May 15, 2020

SELL
$25.53 - $70.14 $121,829 - $334,708
-4,772 Closed
0 $0
Q4 2019

Feb 11, 2020

BUY
$54.18 - $65.64 $54,721 - $66,296
1,010 Added 26.85%
4,772 $260,000
Q3 2019

Nov 14, 2019

BUY
$58.58 - $83.91 $220,377 - $315,669
3,762 New
3,762 $235,000

Others Institutions Holding GKOS

About GLAUKOS Corp


  • Ticker GKOS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 47,596,900
  • Market Cap $7.2B
  • Description
  • Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent, iStent inject, iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-...
More about GKOS
Track This Portfolio

Track Atria Investments LLC Portfolio

Follow Atria Investments LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Atria Investments LLC, based on Form 13F filings with the SEC.

News

Stay updated on Atria Investments LLC with notifications on news.